V.K. Neurocare & Trauma Research Hospital

Name :

V.K. Neurocare & Trauma Research Hospital

Address  :

N-159, Model Town

Town  :

Hisar

State  :

Haryana

Country  :

INDIA

Post Code:

125005

Web URL  :

Specialization
  • Blood Bank
  • Colour Doppler
  • CT Scanning
  • EEG/EMG/Evoked Potential
  • Mammography(Digital)
  • Neuro Surgeon
  • Neurologist
  • Oncologist
  • Orthopedics
  • Paediatrics
  • Urology
  • X-Ray
Facilities

ICU Beds : 7

Total Number Of Beds : 40

Speciality Type :

Super Speciality :

  • Neuro Surgical
  • Neurology
  • Urology
  • Infertility

Other Facilities

  • Pathology
  • X-Ray
  • CT/MRI
  • Physiotherapy

Advance Facility

  • Central Suction Unit
  • C-arm Image Interior
  • Central O2 Facility
  • Blood Bank
  • Medical Stores

Description

Established in Jan1997 VK Neurocare amp Trauma Research Hospital is the first hospital in Haryana to have facilities for Endoscopic Brain amp Spine surgery by Dr VK Gupta an expert neurosurgeon trained at PGI Chandigarh By starting of the hospital a gap of nonavailability of neurosurgeon in the town Hissar has been filled

The latest facilities at hospital has become unsurpassable for the serious patients for the treatment of the head injury brain diseases and as well as same diseases of spine

The staff is dedicated for the cause The organization is soon planning to start a cerebral palsy center for the benefit of the needy patients The organization is already running Welfare Society for Neurological Patients and organizing free camps on every month last Sunday since 1998
Delhi hospital launches helpline for strokes

New Delhi With the number of strokes on the rise Delhis Fortis hospital Tuesday launched a tollfree helpline for victims A statement from the hospital chain said its helpline number 18002003060 can be accessed from both mobiles and landlines in Delhi and the NCR The goal is to get the stroke victim to a hospital as quickly as possible to conf... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More